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Glomerular expression of p27Kip1 in diabetic db/db mouse: Role of
hyperglycemia. Early diabetic nephropathy is characterized by glomerular
hypertrophy. Previous studies in vitro have demonstrated that mesangial
cells exposed to high glucose are arrested in the G1-phase of the cell cycle
and express increased levels of the cyclin-dependent kinase inhibitor
p27Kip1. The present study was performed to investigate the renal expres-
sion of p27Kip1 in db/db mice, a model of diabetes mellitus type II.
Glomerular p27Kip1 protein, but not mRNA expression, was strongly
enhanced in diabetic db/db mice compared with non-diabetic db/1
littermates. Immunohistochemical studies revealed that this stimulated
expression was mainly restricted to the nuclei of mesangial cells and
podocytes, but glomerular endothelial cells occasionally also stained
positively. Quantification of p27Kip1 positive glomerular cells showed a
significant increase of these cells in db/db mice compared with non-
diabetic db/1 animals. Although tubular cells revealed a positive staining
for p27Kip1 protein, there was no difference between db/1 and db/db mice.
Immunoprecipitation experiments revealed that p27Kip1 protein associates
with Cdk2 and Cdk4, but not with Cdk6. To test for the influence of
hyperglycemia on cell cycle arrest and p27Kip1 expression, mesangial cells
were isolated from db/1 and db/db mice. There was a similar basal
proliferation when these cells were grown in normal glucose-containing
medium (100 mg/dl). However, raising the glucose concentration to 275 to
450 mg/dl induced cell cycle arrest in db/1 as well as db/db mesangial cells.
Increasing the medium osmolarity with D-mannitol failed to induce
p27Kip1 expression in mesangial cells. Transfection of cells with p27Kip1
antisense, but not missense, phosphorothioate oligonucleotides facilitated
cell cycle progression equally well in db/1 and db/db mesangial cells.
Furthermore, p27Kip1 expression was comparable in both cell lines in
normal glucose, but increased in high glucose medium. Our studies
demonstrate that p27Kip1 expression is enhanced in diabetic db/db animals.
This induction appears to be due to hyperglycemia. Expression of p27Kip1
may be important in cell cycle arrest and hypertrophy of mesangial cells
during early diabetic nephropathy.
Diabetic nephropathy is a major complication of diabetes
mellitus and is currently one of the major causes of chronic renal
failure. After an initial phase of glomerular hypertrophy associ-
ated with an increase in glomerular filtration rate, the natural
history of diabetic nephropathy is characterized by the develop-
ment of irreversible glomerulosclerosis and tubulointerstitial fi-
brosis causing end-stage renal disease [1–3]. Although originally
considered to be only a feature of insulin-dependent diabetes
mellitus type I (IDDM), there is now ample evidence that similar
features of diabetic nephropathy also occur in patients with
diabetes mellitus type II (NIDDM) [4–6]. In fact, it has been
claimed that patients suffering from NIDDM may even have an
earlier onset of nephropathy than subjects with IDDM [5]. The
pathological lesions are quite similar in NIDDM and IDDM,
underscoring the pathophysiological role of hyperglycemia and/or
substances modified by high glucose such as advanced glycation
end products and Amadori products [7–9].
Mesangial cells (MC) play a key role in the glomerular hyper-
trophy of early diabetic nephropathy [2]. These cells are also
important in the secretion of extracellular matrix proteins that
eventually contribute to the development of glomerulosclerosis.
We and others have previously demonstrated that MC, grown in
high ambient glucose, are growth arrested in the G1-phase of the
cell cycle and undergo cellular hypertrophy [10–12]. This growth
inhibitory effect of high glucose on MC is mediated by synthesis
and bioactivation of transforming growth factor-b (TGF-b) [10].
Furthermore, the high glucose-mediated synthesis of collagen
type IV is also mediated by TGF-b [13, 14]. In a recent series of
experiments we have investigated the role of the cyclin-dependent
kinase (Cdk) inhibitor p27Kip1, a protein that binds to cyclin-Cdk
complexes and inhibit their kinase activity, in high glucose-
mediated cell cycle arrest in MC [15]. These studies revealed that
high glucose increased p27Kip1 protein in MC [15]. Interference
with high glucose-induced p27Kip1 expression applying oligonucle-
otide antisense technology abolished cellular hypertrophy and
facilitated G1-phase exit indicating a pivotal role of p27
Kip1 in MC
growth regulation under conditions of high glucose [15].
The current study was performed to test whether similar
mechanisms may be operative in the kidneys of db/db mice, a
well-characterized model of NIDDM in which early glomerular
expansion resembling that found in human diabetes has been
documented [16–19]. Our data demonstrate that p27Kip1 protein,
but not mRNA, is enhanced in glomeruli of diabetic db/db mice.
Glomerular MC are a likely source of this increase. However,
transfer of isolated MC from db/db mice to normal glucose
containing-cell culture medium reduces the p27Kip1 expression to
Key words: diabetic nephropathy, cyclin-dependent kinases, cell cycle
progression.
Received for publication July 7, 1997
and in revised form October 23, 1997
Accepted for publication October 24, 1997
© 1998 by the International Society of Nephrology
Kidney International, Vol. 53 (1998), pp. 869–879
869
similar levels as MC derived from non-diabetic heterozygotic
db/1 controls. These findings indicate that the increased p27Kip1




Heterozygotic C57BL/Ks-db/1 (db/1) mice were obtained
from Bomholtgard Breeding Center (Ry, Denmark) and a breed-
ing colony was established in our animal facility. Homozygotic
db/db offspring can be identified on the basis of appearance of
obesity around four to six weeks of age [16, 17]. Diabetic db/db
mice as well as their non-diabetic db/1 littermates were studied at
seven weeks of age. The body wt was determined and blood was
drawn from anesthetized animals for the determination of blood
glucose. Kidneys were weighed, pooled from three mice and kept
on ice until further processing. Blood glucose was measured with
B-Glucose analyzer (HemoCue, A¨ngelholm, Sweden).
For selected experiments, insulin-dependent diabetes mellitus
(IDDM) was induced in seven-week-old BALB/c mice (Charles
River, Wiga, Germany) after overnight fasting by the intraperito-
neal injection of a single dose of 200 mg/kg body wt streptozotocin
(STZ; Sigma, Deisenhofen, Germany) [20] dissolved in citrate
buffer (pH 4.5). Blood was obtained from anesthetized mice for
measurement of glucose concentration after injection of STZ.
Only mice with a glucose concentration of 200 to 300 mg/dl after
24 hours were used. At different time points (24 hr to 1 week),
kidneys were removed and glomeruli were isolated by differential
sieving as established in this laboratory [21, 22].
Isolation of glomeruli and cell culture studies
Renal cortices were separated from the medulla, the kidneys
were pooled, minced, and glomeruli were isolated by differential
sieving exactly as previously described [22]. The resulting prepa-
ration contained . 80% glomeruli as judged by light microscopy.
For the establishment of MC cultures, glomeruli were treated
with 0.1% collagenase for 30 minutes, extensively washed, and
plated in small culture flasks (50 ml; Nunc, Roskilde, Denmark) in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco-BRL, Eg-
genstein, Germany) containing 100 mg/dl D-glucose. This me-
dium was supplemented with 10% fetal calf serum, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mM glutamine. The
glomeruli were cultured at 37°C in 5% CO2, and outgrowth of
spindle-like MC could be observed after three to five days. Cells
were passaged after eight days and some cells were grown in glass
slide chambers for further characterization. The identity of mes-
angial origin of the cells was established by positive staining for
desmin and vimentin, but failure of binding to antibodies gener-
ated against factor VIII and proximal tubular cell 3M-1 antigen
(gift of Dr. Eric Neilson, University of Pennsylvania, Philadelphia,
PA, USA).
For 3[H]thymidine incorporation experiments, 104 MC from
either db/1 or db/db mice were plated into each well of a 96-well
culture plate (Nunc) and rested for 24 hours in serum-free
DMEM with 100 mg/dl D-glucose. Cells were then incubated for
another 48 hours in serum-free medium with 100 mg/dl (normal
glucose) or 450 mg/dl (high glucose) D-glucose. Cells were pulsed
with 1 mCi 3[H]thymidine (5 Ci/mmol; Amersham, Braunschweig,
Germany) during the last six hours of culture. After pulsing, MC
were washed twice with PBS, trypsinized for 10 minutes at room
temperature, and finally collected on glass-fiber paper with an
automatic cell harvester. Radioactivity of dry filters was measured
by liquid scintillation spectroscopy. Experiments were indepen-
dently repeated with three different primary MC cultures and four
duplicates for each experiment.
Proliferation experiments were also performed in the presence
of p27Kip1 antisense and missense phosphorothioate oligonucleo-
tides [23]. The following murine sequences were used [24]:
antisense p27Kip1, 59UGGCUCUCCUGCGCC39; and missense
p27Kip1, 59UCCCUUUGGCGCGCC39. Cells were transfected in
serum-free normal glucose medium with 1 mM of either p27Kip1
antisense or missense oligonucleotides using lipofectin [24, 25].
After another 12 hours, the medium was changed to serum-free
normal glucose or high glucose for another 48 hours and cells
were pulsed with 3[H]thymidine as described above.
For Western blots, a total of 106 of primary cultures of MC
derived from either db/1 or db/db mice were incubated for 24
hours in serum-free DMEM with 100 mg/dl D-glucose. Cells were
subsequently incubated for 48 hours in serum-free medium with
different concentrations (100, 275, 333, and 450 mg/dl) of glucose.
In addition, the osmolarity of normal glucose medium was
adjusted with D-mannitol (Sigma), so that the final osmolarity was
equal to high glucose. After washing in ice-cold PBS, cell mono-
layers were directly lysed in lysis buffer (2% SDS, 60 mM Tris-HCl
[pH 6.8], 100 mM dithiothreitol). Lysates were centrifuged and the
supernatants were stored at 220°C until further processing.
Western blots of primary cultures of MC were repeated twice
from independent isolates.
Western blots and immunoprecipitations
Isolated glomeruli from db/1, db/db, or STZ-injected BALB/c
mice (200 ml of glomerular suspension) were lysed in lysis buffer.
After centrifugation the supernatants were transferred to new
tubes. Protein content was measured in all supernatants including
those from lysed MC by a modification of the Lowry method that
is insensitive to the used concentrations of SDS and dithiothreitol
[23]. Protein concentrations were adjusted to 80 mg/sample and
5% glycerol/0.05% bromophenol blue was added. After boiling
for five minutes and centrifugation, supernatants were loaded
onto a denaturing 12% SDS-polyacrylamide gel. Prestained low
molecular weight markers (Amersham), which comprise 2,350 to
45,000 Daltons, served as the molecular weight standards. After
completion of electrophoresis, proteins were electroblotted onto a
nitrocellulose membrane (High-bond-N; Amersham) in transfer
buffer [50 mM Tris-HCl (pH 7.0), 380 mM glycine, 20% methanol].
Filters were stained with Ponceau S to control for equal loading
and transfer. Blocking and detection of p27Kip1 were performed
exactly as previously described [15, 23]. A 1:1000 dilution of a
mouse monoclonal anti-p27Kip1 antibody (Transduction Labora-
tories, Lexington, MA, USA) was used as primary antibody. This
antibody reacts with mouse and rat p27Kip1 [23]. The ECL system
(Amersham) was used for the luminescence detection of horse-
radish peroxidase-conjugated second antibody. Western blots
were independently performed three times from independent
experimental series with qualitatively similar results. Exposed
films were scanned with a laser densitometer (Hoefer Scientific
Instruments, San Francisco, CA, USA), and the area under the
curve was determined by Gaussian integration with the computer
program GS 365W from Hoefer. Signals obtained from db/1
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glomeruli or cells grown in normal glucose were assigned as a
relative value of one.
To determine which Cdk may associate with p27Kip1, immuno-
precipitation experiments were performed on glomerular lysates
of db/1 and db/db mice. A total of 100 ml lysate, 400 ml sterile
water, 500 ml 23 immunoprecipitation buffer (1 3 immunopre-
cipitation buffer: 1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl
(pH 7.4); 2 mM EDTA, 0.2 mM sodium vanadate, 0.2 mM phenyl
methylsulfonylfluoride, 0.5% NP-40], and 5 mg antibody were
mixed and incubated on a shaking-platform on ice for 60 minutes.
Monoclonal anti-Cdk2 and anti-Cdk4 antibodies (both from
Transduction Laboratories) or a polyclonal anti-Cdk6 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) were used. All these
antibodies react with the putative Cdks. To facilitate immunopre-
cipitations, 5 mg polyclonal rabbit anti-mouse IgG (Transduction
Laboratories) was added to the mixtures in which monoclonal
antibodies were used and tubes were incubated for an additional
30 minutes on ice. For immunoprecipitation, 50 ml S. aureus
Cowan strain (Calbiochem-Novabiochem, Bad Soden, Germany)
was added, and tubes continued shaking for another 60 minutes.
Precipitates were formed by centrifugation, washed three times in
ice-cold 13 immunoprecipitation buffer, and the pellets were
resuspended in 40 ml SDS-electrophoresis buffer (2% SDS, 60 mM
Tris-HCl; pH 6.8; 100 mM dithiothreitol, 5% glycerol, 0.03%
bromophenol blue). After boiling for 10 minutes, tubes were
shortly centrifuged, and the supernatants were finally loaded onto
a 12% SDS-polyacrylamide gel. Western blotting and detection of
p27Kip1 were performed as described above. Immunoprecipitation
experiments with subsequent Western blotting were indepen-
dently performed twice with qualitatively similar results.
Isolation of RNA and cDNA amplification
To detect minor changes in p27Kip1 mRNA expression, semi-
quantitative cDNA amplification after reverse transcription of
total RNA was performed exactly as previously described using
the housekeeping RNA of b-actin as an internal control [23].
Isolated glomeruli from six kidneys obtained from db/1 as well as
db/db mice were directly lysed in 4 M guanidinium isothiocyanate,
25 mM sodium citrate (pH 7.0), 0.5% sarcosyl, and 0.1 M 2-mer-
captoethanol. Isolation of total and reverse transcription of total
RNA was performed exactly as previously described [23]. For
cDNA amplification, the following primers were used: p27Kip1
(59GTCTAACGGGAGCCCGAGCCTGG39; 59GAAGGCCGG-
GCTTCTTGGGCG39); b-actin (59GGCCAAGTCATCACTAT-
TGG39, 59GGACTCATCGTACTCCTGC39). A total of 150 ng of
the primers was used. The complete amplification mix without the
primers was equivalently distributed to separate tubes containing
either p27Kip1 or b-actin primers. Reactions were performed using
the GeneAmpy kit (Perkin Elmer Cetus, U¨berlingen, Germany).
Reactions were performed for 30 cycles with an annealing tem-
perature of 60°C for 1.5 minutes, an extension step at 72°C for 1.5
minutes, and a denaturation step at 92°C. Ten microliters of the
reaction product were run on a 1.5% agarose gel containing 0.5
mg/ml ethidium bromide. Bands of the predicted size (p27Kip1, 560
bp; b-actin, 360 bp) were photographed with Polaroid 55 negative
film, and the reaction products on the film were scanned by laser
densitometry. Reverse transcription and cDNA amplification
were independently performed three times.
Immunohistochemistry
Small pieces of kidneys were fixed in Methyl Carnoy’s solution,
embedded in paraffin, and 2 mm thick sections were prepared. For
immunohistochemistry demonstration of p27Kip1, a rabbit poly-
clonal anti-mouse p27Kip1 antibody (Santa Cruz) was used. This
rabbit antiserum was selected instead of the mouse monoclonal
anti-p27Kip1 antibody to prevent non-specific binding of secondary
anti-mouse antibody to nonspecifically trapped IgG in diabetic
mice [26]. Sections were dewaxed, rehydrated and microwave
pretreated. Tissue sections were incubated with a 1:20 dilution of
the rabbit polyclonal anti-p27Kip1 antibody. As additional con-
trols, slides were incubated with normal rabbit serum. The
APAAP complex was used for the visualization of the primary
antibody. Evaluation of p27Kip1-positive cells were performed by
an investigator blinded to the experimental protocol. p27Kip1-
positive cells were counted in at least 10 glomeruli from three
independent animals.
Statistical analysis
Results are expressed as means 6 SEM. Statistical significance
was tested with the Wilcoxon-Mann-Whitney test. A value of P ,
0.05 was considered significant.
RESULTS
db/db and db/1 mice
As predicted, db/db mice at seven weeks after birth revealed a
higher body and kidney weight as well as significantly higher blood
glucose concentrations compared with non-diabetic, age-matched
db/1 littermates (Table 1).
As shown in Figure 1, glomeruli from db/db mice at seven weeks
of age expressed easily detectable amounts of p27Kip1 protein
whereas p27Kip1 expression was hardly detectable in non-diabetic
db/1 littermates (Fig. 1). However, in contrast to protein expres-
sion, there was no difference in glomerular mRNA expression
between db/db and db/1 mice as determined by cDNA amplifi-
cation of reverse-transcribed RNA (Fig. 2). Quantification of
p27Kip1 expression by laser densitometry is given in Table 2.
Immunohistochemistry staining was performed to obtain fur-
ther information on the morphological localization of the in-
creased p27Kip1 protein expression in db/db mice. Since diffuse
linear localization of IgG along the glomerular capillary wall has
been observed in diabetic nephropathy which may be non-
specifically detected by a secondary anti-mouse antibody [26], we
used for our indirect immunohistochemistry studies a rabbit
polyclonal anti-p27Kip1 antiserum with an anti-rabbit secondary
antibody. Furthermore, sections were microwave pretreated
which destroys potential mouse IgG. p27Kip1 staining was princi-
pally localized to nuclei. Only a few, mainly podocytes and
Table 1. Body weight, kidney weight, and blood glucose levels of db/1
and db/db mice 7 weeks after birth
db/1 db/db
Body weight g 23.8 6 1.1 51.5 6 4.3a
Kidney weight g 0.18 6 0.01 0.30 6 0.02a
(left kidney)
Blood glucose mg/dl 103 6 9.3 251 6 18.3a
N 5 8.
a P , 0.001
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endothelial cells, stained positively for p27Kip1 in db/1 mice (Fig.
3A). In contrast, a significant increase in the number of p27Kip1-
positive cells were observed in db/db mice (Fig. 3B). These
positive cells were mainly found in mesangial areas, but occasion-
ally nuclei of endothelial cells were also positive. Quantification of
glomerular p27Kip1-positive cells revealed a significant increase in
db/db mice compared with non-diabetic littermates (db/1 mouse,
1.8 6 0.4; db/db mouse, 5.7 6 1.3 positive cells per glomerulus,
N 5 30, P , 0.01). Although a few nuclei of mainly distal tubuli
irregularly stained positive for p27Kip1, there was no significant
difference between db/1 and db/db mice (data not shown). No
staining was detected when the primary antibody was substituted
with normal rabbit serum, demonstrating the specificity of the
detection (data not shown).
To gain insight into which Cdks may associate with the in-
creased p27Kip1 expression in db/db mice, immunoprecipitation
experiments using specific antibodies against various Cdks with
subsequent Western blotting for p27Kip1 were performed. As
shown in Figure 4A, p27Kip1 associates with Cdk2 as well as with
Cdk4. However, there was no appreciable difference in the
amount of p27Kip1 protein bound to these Cdks in db/1 and db/db
mice. In contrast, p27Kip1 failed to associate with Cdk6 in db/1 as
well as db/db mice (Fig. 4B).
Mesangial cell cultures
Since we have previously demonstrated that increasing the
glucose concentration of the culture medium stimulates p27Kip1
expression in mouse MC cell line, we were interested in whether
the glomerular (mainly mesangial) expression of p27Kip1 in kid-
neys of db/db mice may be due to hyperglycemia or is induced by
different mechanism. To this end, primary cultures of MC from
db/1 and db/db mice were established in normal glucose-contain-
ing medium. Outgrown cells exhibited the typical characteristics
Fig. 1. Western blot for p27Kip1. Isolated glomeruli from seven-week-old
db/1 or db/db mice were lysed, and 80 mg total protein were separated on
an SDS-polyacrylamide gel. There was only very weak expression of
p27Kip1 protein in db/1 mice. In contrast, a strong band was detected in
glomerular lysates from diabetic db/db mice. This blot is representative of
three independent experiments using isolated glomeruli of separate
animals.
Fig. 2. Semiquantitative cDNA amplification of reversed transcribed
total RNA. In contrast to p27Kip1 protein expression, there was no change
in glomerular transcript abundance between db/1 and db/db mice. Parallel
amplification of the housekeeping gene b-actin served as an internal
control. Isolation of total RNA, reverse transcription, and cDNA ampli-
fication were independently performed three times using isolated glomer-
uli from different animals.
Table 2. Quantitative analysis of Western blots by laser densitometry
Experiment Relative densitometric values Significance N
Figure 1 db/1 db/db
1.0 6 0.3 13.5 6 3.8 P , 0.01 3
Figure 5 MC db/1 G100 MC db/1 G450
1.0 6 0.3 12.0 6 4.0 P , 0.01 2
MC db/db G100 MC db/db G450
1.0 6 0.5 9.0 6 2.8 P , 0.01 2
Figure 6 Control STZ
1.0 6 0.7 6.2 6 2.2 P , 0.05 3
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Fig. 3. Immunohistochemistry staining for
p27Kip1 on kidney sections from seven-week-old
db/1 and db/db mice. (A) p27Kip1 expression
was principally localized to nuclei. In db/1 mice
only a few glomerular cells stained positively
for p27Kip1 (arrows). (B) In contrast, the
number of glomerular p27Kip1-positive cells
increased in the kidney of db/db mice (arrows).
There was only occasional positive staining of
tubular nuclei (magnification 3800).
Wolf et al: db/db mouse and p27Kip1 873
of MC including positive staining for desmin and vimentin, but
failed to bind antibodies generated against factor VIII and 3M-1
proximal tubular cell antigen (data not shown). MC from db/1
and db/db mice showed a similar degree of proliferation in normal
glucose (Table 3). In addition, increasing the ambient glucose for
48 hours suppressed proliferation in both cell lines to a similar
extent (Table 3). Treatment of cells with antisense p27Kip1, but
not with missense, oligonucleotides facilitated cell cycle progres-
sion in high glucose medium to a similar extent in MC obtained
from db/1 and db/db (Table 3). There was a comparable baseline
expression of p27Kip1 protein when primary MC cultures from
both mouse strains were cultured in normal glucose medium (Fig.
5A). However, raising the glucose content of the serum-free
medium to 275 to 450 mg/dl stimulated p27Kip1 protein expression
in MC from db/1 as well as db/db mice (Fig. 5B; quantification of
values are provided in Table 2). However, raising the osmolarity
of normal glucose medium (100 mg/dl) with D-mannitol failed to
induce p27Kip1 expression in primary MC cultures from db/1 as
well as db/db mice (Fig. 5B).
Glomerular p27Kip1 expression in streptozotocin-induced
diabetes mellitus
To investigate whether glomerular p27Kip1 expression may also
exist in animals with IDDM, we performed some limited studies
with STZ-induced diabetes mellitus in mice. As shown in Figure 6,
glomerular p27Kip1 expression was strongly stimulated in diabetic
mice 48 hours after injection of a single dose of STZ (quantifica-
tion of densitometric values are provided in Table 2). Diabetic
mice 48 hours after STZ-injection exhibited a blood glucose of
290 6 23.5 mg/dl compared with 87 6 6.7 mg/dl of non-diabetic
controls (N 5 6). Time-course studies revealed that this increased
expression was not present 24 hours after STZ injection; expres-
sion remained elevated one week after administration of STZ
(data not shown).
DISCUSSION
Mesangial matrix expansion and thickening of capillary base-
ment membranes are hallmarks of diabetic nephropathy [2, 27].
Mesangial cell hypertrophy has been linked to the progression of
renal disease in diabetes mellitus [28]. There is strong evidence
that hyperglycemia significantly contributes to these structural
abnormalities [29, 30]. Cell culture studies have provided consid-
erable insight into the mechanisms of how hyperglycemia per se
mediates pathophysiological changes in renal cells. For example,
increasing the glucose concentration of culture medium has a
Fig. 4. Immunoprecipitation experiments using anti-Cdk2, 4 and 6 antibodies with subsequent Western blotting and detection of p27Kip1. (A)
Glomerular lysates were immunoprecipitated with anti-Cdk2 or anti-Cdk4 antibody. Although p27Kip1 associates with Cdk2 and Cdk4, there was no
major difference in the amount of p27Kip1 bound to these Cdks between db/1 and db/db mice. (B) There was no detection of p27Kip1 after
immunoprecipitation with an anti-Cdk6 antibody, indicating that p27Kip1 does not associate in this system with Cdk6. This blot is representative of two
experiments with qualitatively similar changes.
Table 3. 3[H]thymidine incorporation into mesangial cells isolated from
db/1 and db/db mice
db/1 db/db
G 100 1 no oligonucleotides 0.8 6 0.03 1.0 6 0.02
G 450 1 no oligonucleotides 0.5 6 0.02a 0.6 6 0.05a
G 100 1 p27Kip1 missense 1.1 6 0.03 0.9 6 0.07
G 450 1 p27Kip1 missense 0.4 6 0.05a 0.5 6 0.03a
G 100 1 p27Kip1 antisense 1.5 6 0.07b 1.6 6 0.04b
G 450 1 p27Kip1 antisense 2.8 6 0.06c 3.2 6 0.05c
Effect of p27Kip1 antisense and missense phosphorothioate oligonucle-
otides on proliferation in either normal (G 100) or high glucose (G 450)
medium. Data are 3 103 cpm, N 5 12.
a P , 0.01 vs. G100
b P , 0.05 vs. G 100 1 no oligonucleotides
c P , 0.01 vs. G 450 1 no oligonucleotides
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biphasic effect on the growth of MC [10]. After an initial
proliferation, MC are growth arrested in the G1-phase of the cell
cycle, enlarge, and produce more extracellular matrix proteins
[10–14]. We and others have previously demonstrated that the
high glucose-induced cell cycle arrest is mediated by TGF-b [10,
30]. A similar sequence of events (initial proliferation with
subsequent G1-phase arrest) has been described in vivo in the
STZ-induced model of IDDM in rats [31]. Additional factors such
as angiotensin II may contribute to the growth stimulation
mediated by hyperglycemia [32].
Cell growth is controlled by the complex mechanisms that
constitute the cell cycle [33–35]. This cell cycle is divided into four
sequential phases. The period associated with DNA synthesis, the
so-called S-phase, is preceded by the G1-phase in which the cell
prepares its machinery for the subsequent replication of DNA.
During the last decade a universal paradigm has emerged from
genetic studies with yeast as well as information derived from
experiments with marine invertebrates, amphibians, and mamma-
lian cells that the key transitions in the cell cycle are controlled by
the activation of a special family of protein kinases called the
cyclin-dependent kinases (Cdk) [reviewed in 33, 34]. One essential
step in Cdk activation is the assembly of an appropriate cyclin with
Fig. 5. Western blots of mesangial cell (MC) lysates for p27Kip1. Primary MC cultures were established in normal glucose medium from db/1 and db/db
mice. (A) There was similar expression of p27Kip1 when cells from either group of mice were grown in serum-free normal glucose-containing medium
(G100). (B) Incubation of MC for 48 hours in different glucose concentrations (275 to 450 mg/dl, G257-G450) readily induced p27Kip1 expression in MC
from both db/1 and db/db mice compared with normal glucose (100 mg/dl, G100). However, raising the osmolarity of normal glucose medium with 350
mg/dl D-mannitol (G100 1 M 350) failed to stimulate p27Kip1 expression. This blot is representative of two experiments using primary cultures isolated
from different animals.
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its putative Cdk, since only this dimer has the necessary kinase
activity for passing restriction points that induce cell cycle pro-
gression [33, 34]. Cyclins are a family of proteins that are
periodically activated during the cell cycle, and specific cyclin/Cdk
dimers are assembled and activated at different stages in the cell
cycle. The signaling pathways that regulate cell cycle progression
seem to be primarily associated with the G1-phase of the cell
cycle. During this phase, at least two types of cyclins, cyclin D and
E, bind to and activate Cdks during G1, and both are necessary for
S phase to begin. In addition to being pivotal for G1/S-phase
transit, cyclin D/Cdk4 and cyclin E/Cdk2 complexes are both
rate-limiting for completion of the G1-phase. p27
Kip1 is a Cdk
inhibitor that binds to the various G1 cyclin/Cdks complexes and
inhibits their kinase activity, presumably by interacting with the
catalytic cleft for ATP [35]. An increase in p27Kip1 expression has
been associated with cell cycle arrest in various circumstances and
overexpression of p27Kip1 leads to G1-phase arrest in all cell lines
that have been tested so far [36–38].
Since MC that are cultured in high glucose medium are arrested
in the G1-phase, we have recently investigated whether high
glucose-containing medium may influence p27Kip1 expression in
cultured MC. These studies demonstrated that high glucose
medium strongly stimulated p27Kip1 expression, but failed to
influence mRNA abundance [15]. Furthermore, these effects were
independent of the osmolarity of the medium and involved
activation of protein kinase C [15]. p27Kip1 antisense, but not
missense, oligonucleotides inhibited in these in vitro studies high
glucose-stimulated protein synthesis and facilitated G1-phase exit
indicating the central role of p27Kip1 in high glucose-induced MC
hypertrophy [15]. Since potential factors and mechanisms stimu-
lating growth of cultured cells may be fundamentally different
from the in vivo situation, the present study was undertaken to test
whether increased glomerular expression occurs in db/db mice, a
model of NIDDM.
The mutation in the db/db mouse occurred spontaneously in
mice of the C57BL/KsJ strain [17]. Diabetes mellitus in the db/db
mouse is initially expressed as hyperinsulinemia, followed by
hyperphagia and progressive obesity, resulting finally in hypoin-
sulinemia and early death [39]. The db/db mouse is characterized
by a mutation in the leptin receptor (abnormal splicing) with a
missing cytoplasmic tail resulting in an interrupted signaling
pathway [40, 41]. Thus, despite high leptin levels, food consump-
tion is not suppressed in db/db mice. This hyperphagia leads to a
marked increase in the body wt that can be recognized as early as
five weeks of age. The consequence of this increased food
consumption, obesity, and the insulin resistance caused by high
leptin levels, is a syndrome remarkably similar to NIDDM of
humans. Although there are no initial structural abnormalities
between db/db mice and their heterozygotic db/1 littermates,
db/db mice develop a progressive nephropathy during the course
of the disease with early glomerular hyperfiltration associated
with mesangial hypertrophy, and subsequent increases in mesan-
gial synthesis of extracellular matrix proteins such as collagen type
IV and fibronectin causing further expansion of the glomerular
tuft and thickening of the peripheral capillary basal lamina [16, 18,
19, 42–44]. Finally, db/db mice die of renal failure induced by
diffuse glomerulosclerosis and nodular thickening of the glomer-
ular basment membrane. The accumulation of extracellular ma-
trix proteins in kidneys of db/db mice is partly mediated by
increased glycation of serum albumin because an antibody against
Amadori-glycated albumin prevents the development of nephrop-
athy [16].
The present study provides clear evidence that p27Kip1 protein
expression is strongly stimulated in glomeruli of seven-week-old
diabetic db/db mice compared with non-diabetic age-matched
db/1 heterozygotes. At this time point, db/db mice can be clearly
distinguished from their littermates by their obesity, and they
exhibit hyperglycemia and an increase in serum insulin levels. At
seven weeks after birth, db/db mice also have glomerular hyper-
filtration and display glomerular hypertrophy, but they have not
yet developed frank diabetic nephropathy as characterized by
increased extracellular matrix deposition [18, 19, 43]. Since en-
dogenous immunoglobulins may be deposited in the glomerulus
during the course of diabetic nephropathy [26], great care was
taken in selecting antibodies which do not cross-react with mouse
immunoglobulins indicating the specificity of the observed stain-
ing pattern. In addition to db/db mice, we also observed a similar
glomerular distribution of p27Kip1 staining in kidneys from mice
after one week of STZ-induced IDDM (data not shown).
Our immunohistochemistry experiments demonstrated that
p27Kip1 expression was principally localized to cell nuclei. Quan-
tification of p27Kip1-positive glomerular cells revealed a significant
Fig. 6. Western blot for p27Kip1 in glomerular lysates obtained from
BALB/c mice made diabetic with streptozotocin (STZ). In contrast to
controls, there was an increase in p27Kip1 expression in diabetic mice 48
hours after injection of STZ. This increase was not present at 24 hours, but
increased expression remained up to one week (data not shown). Quali-
tatively similar results were obtained in two additional experiments.
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increase in db/db mice compared to non-diabetic db/1 littermates.
In the glomerulus, mainly mesangial cells and podocytes stained
positive, but occasionally glomerular endothelial cells (particular-
ly in db/db mice) exhibited p27Kip1 expression. Although tubular
cells randomly disclosed p27Kip1 positive nuclei, there was no
significant difference between db/1 and db/db animals. Our study
is in agreement with recent observations by Shankland and
co-workers who found p27Kip1 protein expression mainly in nuclei
of mesangial cells, but glomerular endothelial cells also revealed a
positive staining [45].
It is generally acknowledged that isolating a pure glomeruli
preparation from mice is more demanding than from rats. Al-
though our preparation revealed . 80% glomeruli, there was
some tubular contamination. One may therefore ask whether
tubular contamination contributes to the increase p27Kip1 expres-
sion db/db mice. We don’t think that this is likely since only a few
tubular cells stained positively for p27Kip1 and the immunohisto-
chemistry revealed no difference between db/1 and db/db mice.
Along this line, it also seems improbable that size effects (larger
glomeruli from diabetic animals) may explain the difference in
p27Kip1 expression because equal concentrations of protein were
loaded for the Western blot experiments. Assuming that larger
glomeruli from db/db mice would be preferentially harvested,
more control glomeruli would be needed to obtain the same
protein concentration.
In contrast to increased p27Kip1 protein expression, there was
no change in transcript levels as detected by semiquantitative
RT-PCR between db/db mice and their db/1 littermates. This is in
good agreement with previous studies in several cell types dem-
onstrating that changes in p27Kip1 expression may be primarily
regulated by post-transcriptional mechanisms [23, 37, 38]. Al-
though this post-transcriptional regulation of p27Kip1 protein
levels is currently not well understood, studies on colorectal
carcinomas in which p27Kip1 expression is reduced, demonstrated
an increased proteasome-dependent degradation of this Cdk-
inhibitor [46]. Selective proteolysis of Cdk-inhibitors has been also
suggested as one major pathway inducing cell cycle progression in
non-transformed cells [47, 48]. Since a reduction of various renal
proteases has been described in diabetes mellitus [49], such a
decrease in p27Kip1 turnover may contribute to the enhanced
glomerular expression in db/db mice.
We further tested whether mesangial expression of p27Kip1 in
db/db mice is due to hyperglycemia or other factors that may be
present in the leptin resistance background. Mesangial cells were
isolated from db/1 and db/db mice, and p27Kip1 expression was
comparably weak between MC from db/1 and db/db mice when
cells were grown in medium with normal (100 mg/dl) D-glucose.
However, in agreement with previous studies performed in a
mesangial cell line, a strong p27Kip1 protein expression could be
induced by transferring MC into medium with increasing concen-
trations of glucose (275 to 450 mg/dl). An increase in p27Kip1
expression compared with normal glucose was already induced by
an increase in medium glucose concentration (275 to 333 mg/dl)
that is comparable to the blood glucose measured in the diabetic
mice. High glucose-induced p27Kip1 expression was independent
from the medium osmolarity because raising the osmolarity with
D-mannitol failed to stimulate expression of this Cdk inhibitor.
Furthermore, MC from db/1 and db/db mice grow equally well in
medium with normal glucose concentration, but cell cycle arrest
occurred in medium with high glucose. These findings strongly
suggest that mesangial p27Kip1 expression in db/db mice in vivo is
due to hyperglycemia and not due to other factors. Moreover,
limited experiments also demonstrated that glomerular p27Kip1
was strongly enhanced in mice with STZ-induced IDDM indicat-
ing that hyperglycemia per se and not the type or model of
diabetes is pivotal for this stimulation of the Cdk inhibitor.
We have previously shown that high glucose medium induces
p27Kip1 protein in cultured MC and that this induction depended,
at least to some extent, on the endogenous stimulation of TGF-b
[15]. Thus, it is tempting to assume that the cell cycle arrest caused
by high glucose in MC in vivo and in vitro may be mediated by
TGF-b-stimulated expression of p27Kip1. However, recent studies
have clearly demonstrated that p27Kip1 is not necessary for the
antiproliferative effects mediated by TGF-b in MC [50]. In
addition, cell cycle arrest of lymphocytes mediated by TGF-b
remains intact in transgenic mice lacking p27Kip1 [51]. However,
TGF-b may exert antimitogenic effects by several other mecha-
nisms including inhibition of G1-phase Cdk and cyclins and/or
transcriptional activation of IkBa inducing apoptosis [52–55].
It has been previously suggested that p27Kip1 binds to Cdk2,
Cdk4, or Cdk6 with their respective cyclins, and inhibits kinase
activity [36–38]. However, our present immunoprecipitation ex-
periments, although demonstrating binding of p27Kip1 to Cdk2
and Cdk4, but not to Cdk6, failed to show a difference in the
amount of p27Kip1 bound to each Cdk between glomeruli from
db/1 and db/db mice. The reason for this observation is currently
unknown, but some suggestions may be made. The current picture
of Cdk inhibitors suggests that they set an adjustable threshold for
cyclin-dependent activation of the various Cdks. According to this
hypothesis, p27Kip1 is sequestered by Cdk4/cyclin D complexes,
which are needed to overcome a p27Kip1 threshold to become
active when cells progress through the G1-phase [36, 37]. For
example, p27Kip1 may contribute to TGF-b-mediated G1 arrest by
interfering with Cdk2/cyclin E complexes as a result of its release
from cyclin Cdk4/cyclin D complexes due to the TGF-b-mediated
inhibition of Cdk4 production [55]. To explain our findings, one
may assume that in addition to p27Kip1, the synthesis of Cdk2 or
Cdk4 is enhanced in the diabetic environment. Thus, not the
absolute level of p27Kip1 protein, but rather the relationship
among various Cdk-inhibitors and their putative Cdk/cyclin com-
plexes may ultimately regulate cell cycle progression.
In summary, we found that glomerular, mainly mesangial,
p27Kip1 expression is enhanced in db/db mice, a model of
NIDDM. This stimulation is due to hyperglycemia. Since p27Kip1
overexpression is associated with cell cycle arrest, this finding may
explain the glomerular hypertrophy observed in early diabetes.
However, whether this protein is indeed involved in this lesion will
await studies in which induction of diabetes is produced in p27Kip1
negative mice.
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